News

Centerpoint doctor ignored man’s abnormal heart rates before he died, lawsuit alleges
A woman filed a lawsuit saying her husband died after doctors allegedly ignored his abnormal heart readings before his ...
European Medical Journal16h
Two Decades On, Atrial Fibrillation Outcomes Show Uneven Progress
Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks ...
Medscape3d
Interhospital Variability in STEMI Infarction Leads to Differences in Treatment Times, Patient Outcomes
Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...
The Cardiology Advisor1d
Age at AAV Diagnosis Predictive of Myocardial Infarction Risk
Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.
Managed Healthcare Executive1d
Semaglutide More Effective Than Empagliflozin at Lowering Cardiovascular Risks
Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...
The Manila Times1d
A look at Philhealth's new health care coverages
CARDIOVASCULAR diseases (CVDs) continue to be the leading cause of death in the Philippines, with access to timely and ...
Physician's Weekly2d
Growth Factors and Prognosis in Cardiogenic Shock
The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...
News-Medical.Net on MSN4d
Empagliflozin preserves kidney function in heart attack patients
Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...